Efficacy Outcomes from a Phase 3, Randomised, Double-Blind, Placebo-Controlled Study of Fremanezumab for the Preventive Treatment of Episodic Migraine in Children and Adolescents - Hershey, A. D.; Szperka, C. L.; Bittigau, P.; Barash, S.; Garnett, S.; Bryson, J.; Kessler, Y.; Erez, T.; Schwartz, Y. Carmeli; Grozinski-Wolff, M.; Ning, X. (Neuropediatrics, 2025)